glp-1 vs glucagon Glucagon-like peptide 1 in health and disease Mechanisms of glucagon-like peptide 1

107 RuggeriRMGiovinazzoSBarbalaceMCCristaniMAlibrandiAVicchioTMet al

Similar content being viewed by others Introduction Over the past two decades, remarkable progress has been made in the field of cancer metabolism, attracting widespread attention [1]

368 Exclusive enteral nutrition (EEN), the first-line therapy in pediatric patients with active CD, can effectively decrease clinical activity and reduce the complications of CD simultaneously, but its benefit in adults still lacks competent evidence

Cannot redeclare control with same name "grid_1_title_typography_letter_spacing"

The rise of ozempic face: analyzing trends and treatment challenges associated with rapid facial weight loss induced by GLP-1 agonists